Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03255096
Title A Study to Evaluate the Safety, Pharmacokinetics, and Clinical Activity of the Combination of RO6870810 and Venetoclax, With or Without Rituximab, in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | DNK | AUS

Facility Status City State Zip Country Details
City of Hope National Medical Center Duarte California 91010 United States Details
Stanford Cancer Center Stanford California 94305-5820 United States Details
Weill Cornell Medical College New York New York 10065 United States Details
Levine Cancer Institute - Blythe Charlotte North Carolina 28203 United States Details
Peter MacCallum Cancer Centre-East Melbourne Melbourne Victoria 3000 Australia Details
Rigshospitalet; Hæmatologisk Klinik København Ø 2100 Denmark Details
Hospital de la Santa Creu i Sant Pau; Servicio de Hematologia Barcelona 08025 Spain Details
Hospital Duran i Reynals; Servicio de Hematologia Barcelona 08907 Spain Details
START Madrid-FJD, Hospital Fundacion Jimenez Diaz Madrid 28040 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field